These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31696474)

  • 41. Long noncoding RNA LINC00052 suppressed the proliferation, migration and invasion of glioma cells by upregulating KLF6.
    Xu CF; Liu P; Tan J; Hu DF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4822-4827. PubMed ID: 31210314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
    Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level.
    Liu Z; Zhao C; Du S; Gao S; Lu L
    Exp Mol Pathol; 2020 Aug; 115():104476. PubMed ID: 32473153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
    Su WZ; Ren LF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression.
    Hu Z; Wu H; Li Y; Hou Q; Wang Y; Li S; Xia B; Wu S
    Anticancer Drugs; 2015 Jun; 26(5):531-9. PubMed ID: 25646744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
    Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
    Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
    Liu CN; Zhang HY; Liu CL; Wang CC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
    Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Li JY; Ma X; Zhang CB
    Int J Clin Exp Pathol; 2014; 7(11):7938-44. PubMed ID: 25550835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
    Zhang L; Zhou XF; Pan GF; Zhao JP
    Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma.
    Yu BX; Zou L; Li S; Du YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
    Peng CL; Zhao XJ; Wei CC; Wu JW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35904175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.